This dataset includes PRM-based plasma proteomics from adolescent patients diagnosed with Major Depressive Disorder (MDD), Bipolar Disorder (BD), and Schizophrenia (SZ), as well as healthy controls. The study aims to identify differentially expressed proteins and potential circulating biomarkers across psychiatric conditions, enabling evaluation of disease-specific molecular signatures and contributing to the understanding of adolescent psychiatric disorder pathophysiology.